1. Home
  2. Material Detail: SARS-CoV-2 reinfection and implications for vaccine development - PubMed

Material Detail

SARS-CoV-2 reinfection and implications for vaccine development - PubMed

SARS-CoV-2 reinfection and implications for vaccine development - PubMed

Coronavirus disease 2019 (COVID-19) pandemic continues to constitute a public health emergency of international concern. Multiple vaccine candidates for COVID-19, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have entered clinical trials. 

Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Reference Material
Date Added to MERLOT:
August 17, 2021
Date Modified in MERLOT:
August 17, 2021
Author:
Unknown (Know the author?)
Submitter:
Mary Bemker
Primary Audience:
College Lower Division, College Upper Division, Graduate School, Professional
Technical Format:
Website
Mobile Compatibility:
Not specified at this time
Technical Requirements:
Accessed via Google Chrome.
Language:
English
Cost Involved:
No
Source Code Available:
Yes
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as SARS-CoV-2 reinfection and implications for vaccine development - PubMed
People who viewed this also viewed
Other materials like SARS-CoV-2 reinfection and implications for vaccine development - PubMed

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.